Lassa Virus News and Research

RSS
Lassa virus or Lassa viral haemorrhagic fever is an acute illness of 1-4 weeks duration that occurs in West Africa. Though first described in the 1950s, the virus causing the disease was not identified until 1969. The virus is a single-stranded RNA virus belonging to the virus family Arenaviridae. Lassa fever is known to be endemic in Guinea (Conakry), Liberia, Sierra Leone and parts of Nigeria, but probably exists in other West African countries as well.

Further Reading

UTMB researchers receive $11.3 million grant to study immunopathogenesis of Ebola

UTMB researchers receive $11.3 million grant to study immunopathogenesis of Ebola

Researchers present COVID RdRp structure at 2.5A

Researchers present COVID RdRp structure at 2.5A

Using virus-like particles to study SARS-CoV-2 assembly, budding, and entry

Using virus-like particles to study SARS-CoV-2 assembly, budding, and entry

NIAID awards $17 million to establish the Centers for Research in Emerging Infectious Diseases

NIAID awards $17 million to establish the Centers for Research in Emerging Infectious Diseases

Viruses can steal genetic signals from hosts to expand their own genomes

Viruses can steal genetic signals from hosts to expand their own genomes

Remdesivir drug stops novel coronavirus from replicating

Remdesivir drug stops novel coronavirus from replicating

Investigational vaccine protects macaques against four types of hemorrhagic fever viruses

Investigational vaccine protects macaques against four types of hemorrhagic fever viruses

Vaccine for Lassa fever set to enter clinical testing in humans

Vaccine for Lassa fever set to enter clinical testing in humans

Study reveals Lassa virus' soft spot

Study reveals Lassa virus' soft spot

Harvard scientists uncover key mechanism that allows viruses to replicate

Harvard scientists uncover key mechanism that allows viruses to replicate

New disease surveillance tool enables early detection of viral outbreaks

New disease surveillance tool enables early detection of viral outbreaks

A new vaccine shows promise in protecting people from rabies, Lassa fever

A new vaccine shows promise in protecting people from rabies, Lassa fever

New vaccine shows effective protection in animal models of Lassa fever

New vaccine shows effective protection in animal models of Lassa fever

Researchers decipher key component behind rising epidemic of pathogens in West Africa

Researchers decipher key component behind rising epidemic of pathogens in West Africa

Lassa fever epidemic in Nigeria beginning to slow, but concern remains

Lassa fever epidemic in Nigeria beginning to slow, but concern remains

Lassa fever strikes in Nigeria - high rates of fatality with no cure and no vaccine

Lassa fever strikes in Nigeria - high rates of fatality with no cure and no vaccine

Texas Biomed scientists develop new animal model that mimics key features of Zika infection

Texas Biomed scientists develop new animal model that mimics key features of Zika infection

New treatment protects nonhuman primates against Lassa fever eight days after infection

New treatment protects nonhuman primates against Lassa fever eight days after infection

Tulane University receives $12 million NIH grant to develop drug and vaccine against Lassa fever

Tulane University receives $12 million NIH grant to develop drug and vaccine against Lassa fever

Researchers study Lassa fever patient's immune response and viral persistence

Researchers study Lassa fever patient's immune response and viral persistence